India's First Indigenous Hepatitis A Vaccine: Havisure
By Rediff Money Desk, NEWDELHI Jan 19, 2024 17:18
Indian Immunologicals launches Havisure, India's first indigenously developed Hepatitis A vaccine, offering protection against the viral infection.
![India's First Indigenous Hepatitis A Vaccine: Havisure](https://im.rediff.com/money/2020/oct/06vaccine.jpg)
New Delhi, Jan 19 (PTI) Indian Immunologicals on Friday said it has launched the country's first indigenously developed Hepatitis A vaccine.
The vaccine -- Havisure -- represents a significant step forward in the country's fight against Hepatitis A, the company, which is a wholly-owned subsidiary of the National Dairy Development Board (NDDB), said in a statement.
Hepatitis A is a viral infection primarily spread through the fecal-oral route, meaning that it is transmitted through the ingestion of contaminated food or water.
"Currently Hepatitis A vaccines are imported into the country...Havisure has undergone extensive clinical trials in eight centres and has proven to be safe and efficacious," Indian Immunologicals Ltd (IIL) Managing Director K Anand Kumar said.
The vaccine is comparable to the world's leading vaccine sold by multinational companies, he added.
Havisure is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose.
The vaccine -- Havisure -- represents a significant step forward in the country's fight against Hepatitis A, the company, which is a wholly-owned subsidiary of the National Dairy Development Board (NDDB), said in a statement.
Hepatitis A is a viral infection primarily spread through the fecal-oral route, meaning that it is transmitted through the ingestion of contaminated food or water.
"Currently Hepatitis A vaccines are imported into the country...Havisure has undergone extensive clinical trials in eight centres and has proven to be safe and efficacious," Indian Immunologicals Ltd (IIL) Managing Director K Anand Kumar said.
The vaccine is comparable to the world's leading vaccine sold by multinational companies, he added.
Havisure is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- GTL Infrastructure
- 2.93 ( -4.87)
- 226206286
- IFL Enterprises
- 1.30 (+ 4.84)
- 81461564
- Vodafone Idea L
- 16.79 (+ 0.66)
- 67447398
- NCL Research
- 0.95 ( -4.04)
- 31996628
- Franklin Industries
- 3.73 (+ 3.32)
- 21511209
MORE NEWS
![Navi Mumbai...](https://im.rediff.com/80-80/money/2021/jun/10navi-mumbai-airport7.jpg)
Navi Mumbai Airport ILS Signal Testing Begins
The Airports Authority of India (AAI) has begun ILS signal testing at the...
![Air India VRS for...](https://im.rediff.com/80-80/money/2020/sep/09tata-vistara-3.jpg)
Air India VRS for Non-Flying Staff Ahead of...
Air India has announced a voluntary retirement scheme (VRS) and voluntary separation...
Fisher Groups Oppose WTO Fisheries Subsidy Talks
Small-scale fisher groups from India, Indonesia, and Bangladesh demand WTO keep...